- Home
- AACG vs CASI Comparison
AACG vs CASI Comparison
Compare AACG & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACG
- CASI
- Stock Information
- Founded
- AACG 1999
- CASI 1991
- Country
- AACG China
- CASI China
- Employees
- AACG N/A
- CASI N/A
- Industry
- AACG Other Consumer Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- AACG Real Estate
- CASI Health Care
- Exchange
- AACG Nasdaq
- CASI Nasdaq
- Market Cap
- AACG 24.4M
- CASI 20.5M
- IPO Year
- AACG N/A
- CASI 1996
- Fundamental
- Price
- AACG $1.01
- CASI $1.48
- Analyst Decision
- AACG
- CASI Strong Buy
- Analyst Count
- AACG 0
- CASI 1
- Target Price
- AACG N/A
- CASI $4.00
- AVG Volume (30 Days)
- AACG 72.8K
- CASI 79.1K
- Earning Date
- AACG 08-06-2025
- CASI 08-15-2025
- Dividend Yield
- AACG N/A
- CASI N/A
- EPS Growth
- AACG N/A
- CASI N/A
- EPS
- AACG N/A
- CASI N/A
- Revenue
- AACG $37,997,003.00
- CASI $31,368,000.00
- Revenue This Year
- AACG N/A
- CASI N/A
- Revenue Next Year
- AACG N/A
- CASI N/A
- P/E Ratio
- AACG N/A
- CASI N/A
- Revenue Growth
- AACG 21.24
- CASI 8.39
- 52 Week Low
- AACG $0.50
- CASI $1.09
- 52 Week High
- AACG $1.28
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- AACG 57.57
- CASI 54.85
- Support Level
- AACG $1.00
- CASI $1.21
- Resistance Level
- AACG $1.12
- CASI $1.44
- Average True Range (ATR)
- AACG 0.09
- CASI 0.11
- MACD
- AACG 0.02
- CASI 0.03
- Stochastic Oscillator
- AACG 43.15
- CASI 72.97
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.